(19)
(11) EP 3 937 912 A1

(12)

(43) Date of publication:
19.01.2022 Bulletin 2022/03

(21) Application number: 20770054.3

(22) Date of filing: 13.03.2020
(51) International Patent Classification (IPC): 
A61K 31/01(2006.01)
A61K 31/045(2006.01)
A61K 31/015(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/5123; A61K 31/05; A61K 9/10; A61K 9/5169; A61K 9/0019
 
C-Sets:
A61K 31/05, A61K 2300/00;
(86) International application number:
PCT/US2020/022821
(87) International publication number:
WO 2020/186246 (17.09.2020 Gazette 2020/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 13.03.2019 US 201962818041 P

(71) Applicants:
  • Selvaraj, Ulagaraj
    San Antonio TX 78216 (US)
  • Woody, David L.
    San Antonio TX 78216 (US)
  • Boatright, John, H.
    San Antonio TX 78216 (US)
  • Wen, Dong
    San Antonio TX 78216 (US)

(72) Inventors:
  • Selvaraj, Ulagaraj
    San Antonio TX 78216 (US)
  • Woody, David L.
    San Antonio TX 78216 (US)
  • Boatright, John, H.
    San Antonio TX 78216 (US)
  • Wen, Dong
    San Antonio TX 78216 (US)

(74) Representative: Schwarz & Partner Patentanwälte GmbH 
Patentanwälte Wipplingerstraße 30
1010 Wien
1010 Wien (AT)

   


(54) STABILIZED SOLID NANOPARTICLE FORMULATIONS OF CANNABINOIDS AND CANNABINOID ANALOGS WITH REDUCED OSTWALD RIPENING FOR ORAL, INHALATION, NASAL AND PARENTERAL DRUG DELIVERY